Sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia

被引:0
|
作者
Tumuklu, Mevhibe N. [1 ]
Ulas, Halis [1 ]
Akdede, Berna Binnur Kivircik [1 ]
Alptekin, Koksal [1 ]
机构
[1] Dokuz Eylul Univ, Tip Fak, Psikiyatri AD, Izmir, Turkey
来源
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词
Schizophrenia; sexual dysfunction; antipsychotic medications; HALOPERIDOL; CLOZAPINE; SCALE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Sexual dysfunctions are common among patients with schizophrenia. These disorders may also impair the compliance with antipsychotic medications and have a negative impact on quality of life. The objective of this study was to determine the prevalence of sexual dysfunctions and related factors in clinically stable patients who were on antipsychotic treatment. Method: The study population included 76 patients with schizophrenia. Sexual dysfunctions were investigated by UKU (UKU, Udvalg for Kliniske Undersegelser) side effect rating scale. Results: UKU showed that 36.8% of all the patients had decreased sexual desire, and among the male patients 36.2% of them had erectile dysfunction and 23.4% had problems with ejaculation. Among the female patients 20.7% had amenorrhea. The ratio of decreased sexual desire detected by UKU was higher in male patients compared to the ratio in female patients. The patients with decreased sexual desire had higher PANSS negative sub-scores than the ones without decreased sexual desire. Conclusions: These results show that sexual dysfunctions are highly common among patients with schizophrenia. Moreover, these results support the efficiency of UKU side effect rating scale in detecting sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia.
引用
收藏
页码:S27 / S31
页数:5
相关论文
共 50 条
  • [21] Effects of antipsychotic medications on sleep in schizophrenia
    Krystal, Andrew D.
    Goforth, Harold W.
    Roth, Thomas
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (03) : 150 - 160
  • [22] Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications
    Elias, Alan N.
    Hofflich, Heather
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (02) : 98 - 104
  • [23] A global measure to assess switching antipsychotic medications in the treatment of schizophrenia
    Targum, Steven D.
    Pestreich, Linda
    Reksoprodjo, Petra
    Pereira, Heidi
    Guindon, Carrie
    Hochfeld, Marla
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (05) : 455 - 463
  • [24] Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia
    Buckley, PF
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1998, 15 (02) : 113 - 116
  • [25] The Relationship Between Sexual Dysfunctions Polymorphisms in Schizophrenia and Bipolar Disorder Patients Receiving Pharmacotherapy
    Atkaya, Nese Ozturk
    Ozdel, Ismail Osman
    Turel, Samet
    Tepeli, Emre
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [26] Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia
    Rothbard, AB
    Kuno, E
    Foley, K
    SCHIZOPHRENIA BULLETIN, 2003, 29 (03) : 531 - 540
  • [27] Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia
    Xiang, Y. -T.
    Ungvari, G. S.
    Correll, C. U.
    Chiu, H. F. K.
    Shinfuku, N.
    EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2016, 25 (01) : 9 - 17
  • [28] Possible genetic biomarker associated with antipsychotic-induced amenorrhea in female patients with schizophrenia
    Moon, Jung-Joon
    Kim, Ho-Sook
    Shim, Joo-Cheol
    Ahn, Jung-Mee
    Jung, Do-Un
    Kim, Dong-Jin
    Jeong, Hye-Eun
    Kim, Eun-Young
    Jeon, Dong-Wook
    Kim, Sung-Jin
    Shin, Jae-Gook
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (01) : 29 - 35
  • [29] Cognitive improvement in schizophrenia with novel antipsychotic medications
    Purdon, SE
    SCHIZOPHRENIA RESEARCH, 1999, 35 : S51 - S60
  • [30] Predictors of switching antipsychotic medications in the treatment of schizophrenia
    Allen W Nyhuis
    Douglas E Faries
    Haya Ascher-Svanum
    Virginia L Stauffer
    Bruce J Kinon
    BMC Psychiatry, 10